Assessing antiretroviral use during gaps in HIV primary care using multisite Medicaid claims and clinical data
Journal of Acquired Immune Deficiency Syndromes Aug 17, 2017
Monroe AK, et al. – Authors aimed at assessing antiretroviral use during gaps in HIV primary care using multisite Medicaid claims and clinical data. Medicaid–insured individuals commonly receive antiretroviral therapy (ART) during gaps in HIV primary care, but almost half do not. Retention measures based on visit frequency data that do not incorporate receipt of ART and/or viral suppression may misclassify individuals who remain suppressed on ART as not retained.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries